BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1239 related articles for article (PubMed ID: 19035506)

  • 1. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
    Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis.
    Lee JH; Cho ML; Kim JI; Moon YM; Oh HJ; Kim GT; Ryu S; Baek SH; Lee SH; Kim HY; Kim SI
    J Rheumatol; 2009 Apr; 36(4):684-92. PubMed ID: 19228664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis.
    Joosten LA; Heuvelmans-Jacobs M; Lubberts E; van de Loo FA; Bakker AC; Helsen MM; Richards CD; van den Berg WB
    Arthritis Rheum; 2002 May; 46(5):1379-89. PubMed ID: 12115246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2.
    Heinhuis B; Koenders MI; van de Loo FA; van Lent PL; Kim SH; Dinarello CA; Joosten LA; van den Berg WB
    Ann Rheum Dis; 2010 Oct; 69(10):1866-72. PubMed ID: 20472585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
    Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
    van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous interleukin-6, but not tumor necrosis factor alpha, contributes to the development of toll-like receptor 4/myeloid differentiation factor 88-mediated acute arthritis in mice.
    Kyo F; Futani H; Matsui K; Terada M; Adachi K; Nagata K; Sano H; Tateishi H; Tsutsui H; Nakanishi K
    Arthritis Rheum; 2005 Aug; 52(8):2530-40. PubMed ID: 16052598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
    Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
    Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice.
    Abdollahi-Roodsaz S; van de Loo FA; Koenders MI; Helsen MM; Walgreen B; van den Bersselaar LA; Arntz OJ; Takahashi N; Joosten LA; van den Berg WB
    Arthritis Rheum; 2012 Jun; 64(6):1838-47. PubMed ID: 22147588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
    Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.
    Abdollahi-Roodsaz S; Joosten LA; Roelofs MF; Radstake TR; Matera G; Popa C; van der Meer JW; Netea MG; van den Berg WB
    Arthritis Rheum; 2007 Sep; 56(9):2957-67. PubMed ID: 17763416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis.
    Huang Q; Ma Y; Adebayo A; Pope RM
    Arthritis Rheum; 2007 Jul; 56(7):2192-201. PubMed ID: 17599732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.
    Kim HA; Cho ML; Choi HY; Yoon CS; Jhun JY; Oh HJ; Kim HY
    Arthritis Rheum; 2006 Jul; 54(7):2152-63. PubMed ID: 16802353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.